Submitted by Anonymous (not verified) on 1 September 2023 - 11:51
Opinion/decision on a Paediatric investigation plan (PIP): (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4- fluoropyrrolidine-2-carboxamide (ACH-0144471), decision type: , therapeutic area: , PIP number: P/0243/2019
Source: